For research use only. Not for therapeutic Use.
The enzyme fatty acid amide hydrolase (FAAH) is capable of hydrolyzing and inactivating anandamide and other fatty acid amides that act as agonists for the central cannabinoid (CB<sub>1</sub>) receptor. CAY10570 is a reversible competitive inhibitor of FAAH activity exhibiting an IC<sub>50</sub> value of 1.3 µM. CAY10570 has no affinity for the human CB<sub>1</sub> receptor and acts as a competitive inhibitor of FAAH activity without being hydrolyzed by the enzyme.
| Catalog Number | R030865 |
| CAS Number | 875014-22-5 |
| Synonyms | 3-decyl-5,5/’-diphenyl-2-thioxo-4-imidazolidinone |
| Molecular Formula | C25H32N2OS |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Storage | -20°C |
| IUPAC Name | 3-decyl-5,5-diphenyl-2-sulfanylideneimidazolidin-4-one |
| InChI | InChI=1S/C25H32N2OS/c1-2-3-4-5-6-7-8-15-20-27-23(28)25(26-24(27)29,21-16-11-9-12-17-21)22-18-13-10-14-19-22/h9-14,16-19H,2-8,15,20H2,1H3,(H,26,29) |
| InChIKey | ACGQTBAFQLDLFS-UHFFFAOYSA-N |
| SMILES | CCCCCCCCCCN1C(=O)C(NC1=S)(C2=CC=CC=C2)C3=CC=CC=C3 |
| Reference | 1.Cravatt, B.F.,Giang, D.K.,Mayfield, S.P., et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87 (1996). |
